MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Finger tapping-related brain activation and impact of cerebellar theta-burst stimulation in cervical dystonia patients

    T.M. Odorfer, G.A. Homola, J. Volkmann, D. Zeller (Wuerzbuerg, Germany)

    Objective: To assess brain activation during simple movements of the right hand in patients with cervical dystonia (CD) by means of fMRI. To test the…
  • 2016 International Congress

    Parietal hand pseudodystonia: Significant functional gains with ultrasound-guided botulinum toxin treatments

    P. Pita Lobo, C. Costa (Amadora, Portugal)

    Objective: Case report. Background: Symptomatic focal dystonia is most commonly secondary to lesions involving the basal ganglia. Previous reports have documented the occurrence of focal…
  • 2016 International Congress

    Botulinum toxin type B therapy for cervical dystonia – 2015 update of a Cochrane systematic review and meta-analysis

    R.E. Marques, G.S. Duarte, F.B. Rodrigues, M. Castelão, J.J. Ferreira, P. Moore, J. Costa (Lisboa, Portugal)

    Objective: To compare the effects of botulinum toxin type B (BtB) versus placebo in cervical dystonia (CD). Background: This is an update of a Cochrane…
  • 2016 International Congress

    Localization of basal ganglia and thalamic damage in dyskinetic cerebral palsy

    B.R. Aravamuthan, J.L. Waugh (Boston, MA, USA)

    Objective: To quantitatively consolidate published reports of deep grey matter injury in cerebral palsy to determine the patterns of injury associated with dystonia and dyskinesias.…
  • 2016 International Congress

    Association of amyotrophic lateral sclerosis with basal ganglia impairment

    D. Mirzaeva, A. Prokhorova, B. Muinjanov, P. Deleyn (Tashkent, Uzbekistan)

    Objective: The aim of this study is to define extent of basal ganglia involvement in amyotrophic lateral sclerosis (ALS). Methods: The study included 45 patients…
  • 2016 International Congress

    Deep brain stimulation of the locomotor mesencephalic region in rats with lesioned sensorimotor cortex: A model of functional motor recovery after stroke

    F. Fluri, M.K. Schuhmann, C. Kleinschnitz, J. Volkmann (Würzburg, Germany)

    Objective: To evaluate whether electrical stimulation of the locomotor mesencephalic region (LMR) in rats with lesioned sensorimotor cortex improves (1) locomotion assessed by the CatWalk…
  • 2016 International Congress

    Loss of heart rate variability in ALS: Time and frequency domain assessment

    P. Congiu, G. Milioli, G. Borghero, G. Gioi, F. Marrosu, M. Puligheddu, A.L. Goldberger, S. Mariani (Monserratoo, Italy)

    Objective: The aim of this study was to investigate alterations in cardiac autonomic control during sleep in patients affected by ALS. Background: Amyotrophic lateral sclerosis…
  • 2016 International Congress

    Relationship between balance, trunk impairment and hand function in Parkinson’s disease

    B. Donmez Colakoglu, F. Soke, A. Genc, P. Keskinoglu (Izmir, Turkey)

    Objective: Our aim is to examine the relationship between balance, trunk impairment and hand function in patients with PD. Background: Parkinson's disease (PD) is the…
  • 2016 International Congress

    STRONG VOICE: Design of a multisite, open-label, longitudinal registry for patients with neurogenic dysphonia/dysphagia treated with vocal fold augmentation

    K.D. Sethi, A. Verma, C.A. Rosen, C.H. Adler, C.J. Bassich, T.L. Carroll, M.D. Stacy (Raleigh, NC, USA)

    Objective: To describe the benefits and risks of vocal fold augmentation treatment for patients with neurogenic dysphonia/dysphagia. Background: Neurogenic dysphonia/dysphagia represents laryngeal dysfunction, usually with…
  • 2016 International Congress

    Neuroprotection effect of an endogenous amine, 1MeTIQ against disturbances in dopamine release induced by the neurotoxin, 6-OHDA: In vivo microdialysis study

    A. Wasik, I. Romanska, L. Antkiewicz-Michaluk (Krakow, Poland)

    Objective: The aim of the present study was to investigated using microdialysis methodology the impact of 1MeTIQ on the disturbances of in vivo dopamine release…
  • « Previous Page
  • 1
  • …
  • 66
  • 67
  • 68
  • 69
  • 70
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley